Freenome
Healthcare & Life Sci
Company overview
Freenome develops blood-based screening tests for early cancer detection. It combines science with artificial intelligence to build a medical AI platform that detects cancer in its earliest stages. Its flagship product, SimpleScreen CRC, is an FDA-approved blood test for colorectal cancer screening.
Freenome has raised $1.35 billion in funding to date. Historically, the median salary is ~$192,500. Freenome is an H-1B sponsor.
- Industry
- Healthcare & Life Sci
- Headquarters
- Brisbane, United States